ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PRTC Puretech Health Plc

222.50
-2.50 (-1.11%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Puretech Health Plc LSE:PRTC London Ordinary Share GB00BY2Z0H74 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.50 -1.11% 222.50 223.50 225.00 227.00 222.00 226.00 195,253 16:35:03
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Home Health Care Services 23.75M -50.35M -0.1839 -12.18 613.46M

PureTech Health PLC PureTech to Present at Leerink Conference

07/02/2017 7:00am

RNS Non-Regulatory


TIDMPRTC

PureTech Health PLC

07 February 2017

7 February 2017

PureTech Health plc

PureTech Health to Present at the Leerink Partners 6th Annual Global Healthcare Conference

PureTech Health plc (LSE: PRTC), a cross-disciplinary biopharmaceutical company, today announced that Daphne Zohar, PureTech Health's Chief Executive Officer, will present at the Leerink Partners 6th Annual Global Healthcare Conference on Thursday, 16 February, at 2:00pm EST.

A webcast of the presentation will be available at http://puretechhealth.com/investors.php under the Reports and Presentations tab.

About PureTech Health

PureTech Health (PureTech Health plc, PRTC.L) is a cross-disciplinary biopharmaceutical company creating 21(st) century medicines that modulate the adaptive human systems. Our therapies target the immune, nervous, and gastro-intestinal systems by addressing the underlying pathophysiology of disease from a systems perspective rather than through a single receptor or pathway. We have multiple human proof-of-concept studies and pivotal or registration studies expected to read out in the next two years. PureTech Health's rich and growing research and development pipeline has been developed in collaboration with some of the world's leading scientific experts who, along with PureTech's experienced team and board, analyse more than 650 scientific discoveries per year to identify and advance only the opportunities we believe hold the most promise for patients. This team and process place PureTech Health on the cutting edge of ground-breaking science and technological innovation and leads the Company between and beyond existing disciplines. For more information, visit www.puretechhealth.com or connect with us on Twitter.

Forward Looking Statement

This press release contains statements that are or may be forward-looking statements, including statements that relate to the company's future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks and uncertainties described in the risk factors included in the regulatory filings for PureTech Health plc. These forward-looking statements are based on assumptions regarding the present and future business strategies of the company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law and regulatory requirements, neither the company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

For further information:

 
     Media:   Allison Mead 
               +1 617 651 3156 
               amead@puretechhealth.com 
 Investors:   Graham Morrell 
               +1 617 986 1659 
               gm@puretechhealth.com 
 
 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRATFMJTMBTMTLR

(END) Dow Jones Newswires

February 07, 2017 02:00 ET (07:00 GMT)

1 Year Puretech Health Chart

1 Year Puretech Health Chart

1 Month Puretech Health Chart

1 Month Puretech Health Chart

Your Recent History

Delayed Upgrade Clock